 The Chronicle began covering the coronavirus crisis before the first cases were reported in the Bay Area and a pandemic was declared. We reorganized the newsroom to dedicate nearly every resource to stories focusing on the health and economic disasters. Every day we have published live updates to reflect the most critical local, national and global updates on COVID-19, and this news is free of charge in an effort to keep our community safe and informed. Read the previous batch of updates from June 14-15. Read the previous batch of updates from June 18-19. See the full timeline. Updates from Wednesday, June 17: 11:45 p.m. Study suggests blood type could influence COVID-19 risk: An analysis of thousands of coronavirus patients in Europe found that people with Type A blood were more likely to develop a severe case of COVID-19 while people with Type O blood were less likely, according to an AP report. The analysis, published in the New England Journal of Medicine, suggests that genetic variations and blood groups could play a part in how susceptible people are to the virus. 11:27 p.m. WHO ends trial of hydroxychloroquine: The World Health Organization said it has stopped testing the antimalarial drug hydroxychloroquine for COVID-19 patients after studies showed no benefit, according to Reuters. Data from a multi-country WHO trial and a separate UK-led trial showed the drug does not result in the reduction of... 